Skip to main content

Contents

Go back
Overview
Stability Information
Alternative Suppliers
Related Formulations

Actual Medicinal Product (AMP) Oxybutynin 5mg modified-release tablets (A A H Pharmaceuticals Ltd)

Stability Information

Stability
We do not have stability information for these medicines and therefore cannot make a recommendation on suitability in an MCA.
Notes
There are no stability notes available for this medicine.
Generic
Oxybutynin
Formulation
Oxybutynin 5mg modified-release tablets
  • Oxybutynin
    • Oxybutynin 5mg modified-release tablets
      • Oxybutynin 5mg modified-release tablets (A A H Pharmaceuticals Ltd)

Alternative Suppliers (9)

Oxybutynin 5mg modified-release tablets (Accord Healthcare Ltd)
Oxybutynin 5mg modified-release tablets (Alliance Healthcare (Distribution) Ltd)
Oxybutynin 5mg modified-release tablets (A A H Pharmaceuticals Ltd)
Ditropan XL 5mg tablets (Janssen-Cilag Ltd)
Lyrinel XL 5mg tablets (Janssen-Cilag Ltd)
Lyrinel XL 5mg tablets (Waymade Healthcare Plc)
Lyrinel XL 5mg tablets (Mawdsley-Brooks & Company Ltd)
Oxybutynin 5mg modified-release tablets (Accord-UK Ltd)
Oxybutynin 5mg modified-release tablets (Aspire Pharma Ltd)


Related Formulations (7)

Oxybutynin 3mg tablets
Oxybutynin 2.5mg tablets
Oxybutynin 5mg tablets
Oxybutynin 3.9mg/24hours transdermal patches
Oxybutynin 5mg/30ml bladder irrigation pre-filled syringes
Oxybutynin 5mg modified-release tablets
Oxybutynin 10mg modified-release tablets